3 Results for "

QSAR study

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "QSAR study" in MCE Product Catalog:

Cat. No.: HY-101087
CAS No.: 98-10-2
Purity:  99.41%
Benzenesulphonamide (Compound 1) is a carbonic anhydrase inhibitor. Benzenesulphonamide exhibits CA II inhibitory activity. Benzenesulphonamide reduces ROS and improves the gene expression of amyloid-β40 and 42. Benzenesulphonamide is beneficial for Alzheimer's disease. Benzenesulphonamide derivatives have anticancer, anti-inflammatory, and anticonvulsant activities. Benzenesulphonamide can be used in the research of Alzheimer's disease, epilepsy, inflammatory diseases, leukemia, melanoma, lung cancer, and colon cancer .
loading...
    loading...
Cat. No.: HY-101087R
CAS No.: 98-10-2
Benzenesulphonamide (Standard) is the analytical standard of Benzenesulphonamide (HY-101087). This product is intended for research and analytical applications. Benzenesulphonamide (Compound 1) is a carbonic anhydrase inhibitor. Benzenesulphonamide exhibits CA II inhibitory activity. Benzenesulphonamide reduces ROS and improves the gene expression of amyloid-β40 and 42. Benzenesulphonamide is beneficial for Alzheimer's disease. Benzenesulphonamide derivatives have anticancer, anti-inflammatory, and anticonvulsant activities. Benzenesulphonamide can be used in the research of Alzheimer's disease, epilepsy, inflammatory diseases, leukemia, melanoma, lung cancer, and colon cancer .
loading...
    loading...
Cat. No.: HY-184400
CAS No.: 2034366-97-5
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Pynazolam is a predicted positive allosteric modulator of GABAA receptor. 3D-field QSAR and RVM models predict an IC50 of approximately 0.40 nM. Pynazolam can be used in studies related to GABAA receptor pharmacology .
loading...
    loading...